Trials / Completed
CompletedNCT04113239
Study of the Genome, Gut Metagenome and Lifestyle of Patients With Incident Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- Atlas Biomed · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A case-control study to identify microbiome and genetic differences between healthy people and patients with incident type 2 diabetes mellitus.
Detailed description
Two groups of people, one composed of healthy volunteers and the other of patients with incident type 2 diabetes mellitus who never received treatment for their condition, fill in the food frequency questionnaire and the physical activity questionnaire. DNA microarray genotyping is used to process the DNA samples of the participants. The data on the composition of the participants' gut microbiota is obtained through sequencing of their stool samples.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | 16S rRNA gene sequencing | Taking a stool sample for gut microbiome DNA sequencing |
| GENETIC | DNA-microarray genotyping | Taking a saliva sample for genotyping |
Timeline
- Start date
- 2019-11-27
- Primary completion
- 2021-10-20
- Completion
- 2021-11-25
- First posted
- 2019-10-02
- Last updated
- 2022-07-20
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT04113239. Inclusion in this directory is not an endorsement.